In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 8, 2024), CVS HEALTH Corp reported 5 stock positions worth $230.2 million . Its top holding was SS SPDR S&P 500 ETF Trust-US (SPY) at 71.8% of the portfolio, followed by Vanguard High DVD Yield ETF (VYM, 14.0% ) and iShares Core High Dividend E (HDV, 14.0% ). Its holdings were unchanged from Q2 2024.
Location WOONSOCKET, RI
CIK 0000064803
Portfolio Value $230.2M (Q3 2024) Holdings 5 stocks · $230.2M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q2 2024 SPY SS SPDR S&P 500 ETF Trust-US 71.75% 287,891 $165.2M No change VYM Vanguard High DVD Yield ETF 14.04% 252,032 $32.3M No change HDV iShares Core High Dividend E 13.95% 273,110 $32.1M No change PRU Prudential Financial Inc. 0.14% 2,683 $325K No change HCAT Health Catalyst Inc. 0.11% 32,273 $263K No change
Portfolio Sells Q2 2024 → Q3 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2024 % Of Portfolio Change To Portfolio ▲ None this quarter.
Portfolio Buys Q2 2024 → Q3 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2024 % Of Portfolio Change To Portfolio ▼ None this quarter.
Notes & Other Activity Q2 2024 → Q3 2024 Security Class Change vs Q2 2024 Shares / Principal Value ▼ LMDWF Lumiradx Ltd. -CW26 *W EXP 09/28/202 Sold out 5,352,106 $73Kbefore exit
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 21 $225.2M IGSB, IGIB, IEI, SHY, USHY Q1 2026 33 $212.3M SPY, IEI, SHY, IGSB, AGG Q4 2025 9 $135.3M SPY, USHY, IGIB, JAAA, IGSB Q3 2025 3 $102.9M SPY, PRU, HCAT Q2 2025 3 $190.6M SPY, PRU, HCAT Q1 2025 3 $172.7M SPY, PRU, HCAT Q4 2024 3 $233.7M SPY, PRU, HCAT Q3 2024 5 $230.2M SPY, VYM, HDV, PRU, HCAT Q2 2024 5 $216.8M SPY, VYM, HDV, PRU, HCAT Q1 2024 5 $211.7M SPY, VYM, HDV, PRU, HCAT